Transhepatic central venous catheter for long-term access in paediatric patients

Mortell, Alan; Said, Hanan; Doodnath, Reshma; Walsh, Kevin; Corbally, Martin

doi:10.1016/j.jpedsurg.2007.10.044

Cited by 18 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our complication rate of 39.7 complications per 1,000 catheter-days was higher, compared with an overall transhepatic central catheter complication rate of 2.3-14.2 per 1,000 catheter-days previously reported (2,8,10). Given the descriptive nature of these reports, our study is the first to evaluate the risk factors associated with transhepatic catheter complications.…”

Section: Discussioncontrasting

confidence: 46%

“…Previous articles evaluating transhepatic catheters report mortality rates of 20-40% (2,8,10). Qureshi et al (8) evaluated 40 transhepatic broviac catheters placed in 32 patients with a mortality rate of 21.8% at a median follow-up of 3.5 months.…”

Section: Discussionmentioning

confidence: 99%

“…Unconventional access includes inferior vena cava (IVC) access via the translumbar approach (2)(3)(4), direct right atrial access via thoracotomy (5), intercostal venous access (6), and azygos venous access (7). The most common unconventional venous access for congenital heart disease patients outside of the perioperative period is transhepatic central venous access (2,3,(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). Transhepatic access has been described in many small case series as being a reliable option for patients with limited venous access or in cases where traditional percutaneous access sites need to be preserved.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Transhepatic Central Venous Catheters in Pediatric Patients With Congenital Heart Disease

Boe

Zampi²,

et al. 2015

Pediatric Critical Care Medicine

View full text Add to dashboard Cite

Transhepatic central venous catheters represent a viable option for patients with limited access. Polyurethane catheters and catheter duration at least 21 days are associated with increased transhepatic central venous catheter complications. Although complication rates are higher than more traditional forms of central venous catheters, the long duration of hospitalization and high mortality rates in this patient population attest to their risks for poor outcomes irrespective of venous access.

show abstract

Section: Discussioncontrasting

confidence: 46%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Transhepatic Central Venous Catheters in Pediatric Patients With Congenital Heart Disease

Boe

Zampi²,

et al. 2015

Pediatric Critical Care Medicine

View full text Add to dashboard Cite

show abstract

“…Translumbar and transhepatic inferior vena cava access are more technically difficult. Transhepatic access is associated with greater mechanical instability, higher short‐term and long‐term complication rates, and risk of infection . Hemizygos or azygos collaterals are feasible albeit rarely used.…”

Section: Failure Points and Essential Components Of Carementioning

confidence: 99%

“…Transhepatic access is associated with greater mechanical instability, higher short-term and long-term complication rates, and risk of infection. [50][51][52][53] Hemizygos or azygos collaterals are feasible 54 albeit rarely used. Transthoracic transatrial access 51,55 is sometimes performed at the time of cardiac surgery.…”

Section: Elective Access Conditionsmentioning

confidence: 99%

Evidence‐Based Strategies and Recommendations for Preservation of Central Venous Access in Children

Baskin

Mermel

Saad

et al. 2019

J Parenter Enteral Nutr

View full text Add to dashboard Cite

Children with chronic illness often require prolonged or repeated venous access. They remain at high risk for venous catheter–related complications (high‐risk patients), which largely derive from elective decisions during catheter insertion and continuing care. These complications result in progressive loss of the venous capital (patent and compliant venous pathways) necessary for delivery of life‐preserving therapies. A nonstandardized, episodic, isolated approach to venous care in these high‐need, high‐cost patients is too often the norm, imposing a disproportionate burden on affected persons and escalating costs. This state‐of‐the‐art review identifies known failure points in the current systems of venous care, details the elements of an individualized plan of care, and emphasizes a patient‐centered, multidisciplinary, collaborative, and evidence‐based approach to care in these vulnerable populations. These guidelines are intended to enable every practitioner in every practice to deliver better care and better outcomes to these patients through awareness of critical issues, anticipatory attention to meaningful components of care, and appropriate consultation or referral when necessary.*

show abstract

Nutrition for the Preterm Neonate

Patole¹

2013

View full text Add to dashboard Cite

Survival of extremely preterm neonates (gestation within 28 weeks from birth) has improved significantly following the advances in neonatal intensive care. Extra uterine growth restriction is a serious issue in this population. Nutritional exposures during this critical period in life influence the individual's risk of disease throughout life. Nutritional deficit and poor growth are associated with long term neurodevelopmental impairment, short stature and metabolic disorders in extremely preterm neonates. Optimising nutrition in the early postnatal life of the preterm neonate is therefore a priority. However this is easier said than done, considering the frequency of feed intolerance, fear of necrotising enterocolitis and the hesitancy in adopting an aggressive approach to parenteral nutrition in this population.Some of the finest researchers in the field have come together to provide the clinical perspective on the A to Z of nutrition in the preterm neonate in simple and clear fashion in this book. I am grateful to all authors for their valuable contributions, the quality of which reflects their expertise as clinicians and researchers. The topics that are covered range from the developmental physiology of the gastrointestinal tract, to aggressive enteral and parenteral nutrition, and feeding under special conditions such as intrauterine growth restriction and chronic lung disease. I hope that with its practical approach this book will be useful for everyone involved in neonatal intensive care and also for those aiming for an academic career in this field.I would also like to take this opportunity to thank Springer and their publishing editor Thijs van Vlijmen, for encouragement and support in getting this unique book published in a remarkably short period. I hope the readers appreciate the purpose and the passion behind this book.

show abstract

Transhepatic central venous catheter for long-term access in paediatric patients

Cited by 18 publications

References 24 publications

Transhepatic Central Venous Catheters in Pediatric Patients With Congenital Heart Disease

Transhepatic Central Venous Catheters in Pediatric Patients With Congenital Heart Disease

Evidence‐Based Strategies and Recommendations for Preservation of Central Venous Access in Children

Nutrition for the Preterm Neonate

Contact Info

Product

Resources

About